![]() |
市場調查報告書
商品編碼
1375211
南美洲和中美洲生物製程技術市場預測至 2028 年 - 按類型、模式和最終用戶進行的區域分析South & Central America Bioprocess Technology Market Forecast to 2028 - Regional Analysis By Type, Modality, and End User |
南美洲和中美洲生物製程技術市場預計將從2023年的15.3147億美元成長到2028年的33.6113億美元。預計2023年至2028年年複合成長率為17.0%。
引進先進的生物製程技術推動南美洲和中美洲生物製程技術市場
先進的生物製程技術將研發與生產連結起來。一些參與者正在市場上引入各種新的生物加工技術。 2020 年 12 月 4 日,IDBS(生物技術和製藥行業軟體資訊學解決方案提供商)宣布推出 Polar。 Polar 創建了一個名為生物製藥生命週期管理 (BPLM) 的新產品類別,以簡化生物製藥研究中的藥物開發和生產。 Polar 的設計和部署旨在快速解決與工作流程、流程品質、協作和資料分析相關的挑戰,這些挑戰一直困擾著現有的軟體解決方案,包括實驗室資訊管理系統(LIMS) 和電子實驗室筆記本(ELN)。因此,人為錯誤將會減少,整體準確度也會提高。它將減少手動資料處理和轉錄,從而減少人為錯誤並提高整體準確性。它還具有廣泛的搜尋功能,使用戶可以更輕鬆地找到他們正在搜尋的內容,從而避免無意義的重複工作。
梅特勒-托利多的 Dynochem Biologics 是一款專用模擬軟體,支援任何規模的生物加工中的上游和下游單元活動。生物製程工程師和科學家使用該軟體選擇適當的製程操作參數並建立等效規模。實用程式可以用最少的資料快速評估設備性能,而更有效的模型則利用現有的資料流進行製程表徵。透過快速回應的應用專業知識、豐富的培訓資源和已建置的模型庫,可以快速完成初始專案。勝肽、單株抗體、疫苗接種和病毒載體只是眾多應用中的幾個例子。
默克的全新 BioContinuum 平台透過提高效率、簡化工廠運作以及更高的品質和一致性來推進生物治療藥物的生產。此外,默克的 Pellicon 單通道切向流過濾有助於強化與治療性蛋白質純化相關的操作。因此,各種新時代生物程序技術的引入可能會在預測期內為市場成長提供利潤豐厚的機會。
南美洲和中美洲生物製程技術市場概況
根據美國國立衛生研究院 (NIH) 的報告,生物製程活動使用巴西菌株生產純化蛋白衍生物 (PPD),用於診斷用途。在巴西,醫療保健系統在各個地區進口和分發 PPD。進行 PPD 的本土生產是為了啟動研究,利用從巴西各地結核病患者體內分離出的結核分枝桿菌菌株來開發本土 PPD 生產技術。因此,PPD 在單獨測試時顯示出類似的跡象,並且獲得了更好的結果。透過菌株生產用於標靶治療的菌株的這種進步是預測期內南美洲和中美洲生物製程技術市場顯著成長的原因。
南美洲及中美洲生物製程技術市場收入及 2028 年預測(百萬美元)
南美洲和中美洲生物製程技術市場細分
南美洲和中美洲生物製程技術市場按類型、模式、最終用戶和國家進行細分。
根據類型,南美洲和中美洲生物製程技術市場分為細胞培養基生物製程、色譜生物製程、消耗品和配件等。 2023年,消耗品和配件領域在南美洲和中美洲生物製程技術市場中佔據最大佔有率。
根據形態,南美洲和中美洲生物加工技術市場分為一次性使用和多次使用。 2023 年,一次性細分市場在南美洲和中美洲生物製程技術市場中佔據更大佔有率。
根據最終用途,南美洲和中美洲生物製程技術市場分為學術和醫療機構、生物製藥公司、研究實驗室等。 2023年,生物製藥公司細分市場在南美洲和中美洲生物製程技術市場中佔據最大佔有率。
根據國家/地區,南美洲和中美洲生物製程技術市場分為巴西、阿根廷以及南美洲和中美洲其他地區。 2023 年,南美洲和中美洲其他地區在南美洲和中美洲生物製程技術市場中佔據最大佔有率。
丹納赫公司;艾本德公司;龍沙集團股份公司;默克公司;雷普利根公司;賽多利斯公司;和賽默飛世爾科技公司是南美洲和中美洲生物製程技術市場上的一些主要公司。
The South & Central America bioprocess technology market is expected to grow from US$ 1,531.47 million in 2023 to US$ 3,361.13 million by 2028. It is estimated to grow at a CAGR of 17.0% from 2023 to 2028.
Introducing Advanced Bioprocess Technologies Drives South & Central America Bioprocess Technology Market
Advanced bioprocess technologies bridge R&D with production. Several players are introducing a wide range of new bioprocessing technologies in the market. On December 4, 2020, IDBS (a provider of software informatics solutions for the biotech and pharmaceutical industries) announced the launch of Polar. Polar creates a new product category called BioPharma Lifecycle Management (BPLM) to streamline drug development and production in biopharma research. Polar is designed and deployed to rapidly solve challenges associated with workflow, process quality, collaboration, and data analysis that have plagued the existing software solutions, including laboratory information management system (LIMS) and electronic laboratory notebook (ELN). As a result, there will be less human errors and an improvement in overall accuracy. It will reduce manual data processing and transcription, leading to fewer human errors and enhanced overall accuracy. It also has extensive search features that make it easier for users to locate what they are searching for, preventing the need for pointless duplication of effort.
METTLER TOLEDO's Dynochem Biologics is a purpose-built simulation software that supports upstream and downstream unit activities in bioprocessing at any scale. Bioprocess engineers and scientists use the software to choose appropriate process operating parameters and establish scales equivalency. Utilities enable quick evaluation of equipment performance with minimal data, whereas more potent models leverage the existing data streams for process characterization. Initial projects can be completed quickly with the help of responsive application expertise, rich training resources, and a model library that is already built. Peptides, mAbs, vaccinations, and viral vectors are a few examples of the many applications.
Merck's new BioContinuum Platform advances biotherapeutic drug manufacturing through improved efficiency, simplified plant operations, and greater quality and consistency. In addition, Merck's Pellicon Single-Pass Tangential Flow Filtration aid in intensifying operations associated with the purification of therapeutic proteins. Thus, the introduction of various new-age bioprocess technologies is likely to provide lucrative opportunities for the market growth during the forecast period.
South & Central America Bioprocess Technology Market Overview
The bioprocess activity produces purified protein derivative (PPD) using Brazilian strains intended for diagnostic use, per the National Institute of Health (NIH) report. In Brazil, the healthcare system imports and distributes the PPD across various areas. The indigenous production of PPD was undertaken to initiate studies toward developing an indigenous technology for PPD production using the strains of Mycobacterium tuberculosis isolated from patients suffering from TB across Brazil. Therefore, PPD reveals similar indications when tested individually, and better results were obtained. Such advancements in producing strains for targeted therapy through strains are responsible for significant growth for the South & Central America bioprocess technology market during the forecast period.
South & Central America Bioprocess Technology Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Bioprocess Technology Market Segmentation
The South & Central America bioprocess technology market is segmented into type, modality, end user, and country.
Based on type, the South & Central America bioprocess technology market is segmented into cell culture media bioprocess, chromatography bioprocess, consumables & accessories, and others. In 2023, the consumables & accessories segment registered the largest share in the South & Central America bioprocess technology market.
Based on modality, the South & Central America bioprocess technology market is bifurcated into single use and multiple use. In 2023, the single use segment registered a larger share in the South & Central America bioprocess technology market.
Based on end-use, the South & Central America bioprocess technology market is segmented into academic & medical institutions, biopharmaceutical companies, research laboratories, and others. In 2023, the biopharmaceutical companies segment registered the largest share in the South & Central America bioprocess technology market.
Based on country, the South & Central America bioprocess technology market is segmented into Brazil, Argentina, and the Rest of South & Central America. In 2023, the Rest of South & Central America segment registered a largest share in the South & Central America bioprocess technology market.
Danaher Corp; Eppendorf SE; Lonza Group AG; Merck KGaA; Repligen Corp; Sartorius AG; and Thermo Fisher Scientific Inc are some of the key companies operating in the South & Central America bioprocess technology market.